These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17977411)

  • 1. [Spontaneous proliferative response in patients with chronic renal allograft insufficiency due to chronic rejection].
    Savin M; Ramić Z; Mostarica-StojkovićM ; Djukanović Lj
    Srp Arh Celok Lek; 1994; 122(5-6):142-5. PubMed ID: 17977411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of laboratory tests for differential diagnosis of acute renal allograft rejection and acute cyclosporine nephrotoxicity].
    Simić-Ogrizović S; Djukanović Lj; Golubović M; DimitrijevićZ ; Mimić-Oka J; Simić T
    Srp Arh Celok Lek; 1994; 122(5-6):133-6. PubMed ID: 17977408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct cell mediated lympholysis by peripheral blood lymphocytes from renal allograft recipients.
    Grunnet N; Kristensen T
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):41-4. PubMed ID: 133456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte spontaneous blastogenesis as a monitor of renal allograft rejection.
    Kanda H; Uemura T; Kunikata S; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Feb; 36(2):109-14. PubMed ID: 2343802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft nephropathy.
    Ponticelli C
    N Engl J Med; 2004 Mar; 350(12):1254-6; author reply 1254-6. PubMed ID: 15028831
    [No Abstract]   [Full Text] [Related]  

  • 11. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
    Marcard T; Ivens K; Grabensee B; Willers R; Helmchen U; Rump LC; Blume C
    Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic allograft nephropathy.
    Pietrzyk M; Hoffmann U; Krämer BK
    N Engl J Med; 2004 Mar; 350(12):1254-6; author reply 1254-6. PubMed ID: 15031859
    [No Abstract]   [Full Text] [Related]  

  • 14. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic rejection: an enduring enigma of transplantation biology.
    Vanikar AV; Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):773-8. PubMed ID: 17445596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor expression in patients with renal allograft dysfunction.
    Kwon J; Park J; Lee D; Kim YS; Jeong HJ
    Transplant Proc; 2008 Dec; 40(10):3479-80. PubMed ID: 19100417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
    Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
    Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal graft rejection after allogeneic peripheral-blood stem cell transplantation.
    Barraclough KA; Robinson KL; Dowling JP; Schwarer AP; Perry GJ
    Am J Kidney Dis; 2006 Nov; 48(5):822-6. PubMed ID: 17060002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.